TERT.-BUTYL-(2S)-2-TERT.-BUTOXYCARBONYLAMINO-3-(4-OXOPYRIDO-[1,2-A]-PYRIMIDIN-3-YL-)-PROPIONATE
Compound with spectra: 1 NMR
![TERT.-BUTYL-(2S)-2-TERT.-BUTOXYCARBONYLAMINO-3-(4-OXOPYRIDO-[1,2-A]-PYRIMIDIN-3-YL-)-PROPIONATE](/api/compound/2c0HTPb6aAS.png?ph=true&h=300&w=458 "TERT.-BUTYL-(2S)-2-TERT.-BUTOXYCARBONYLAMINO-3-(4-OXOPYRIDO-[1,2-A]-PYRIMIDIN-3-YL-)-PROPIONATE")
| SpectraBase Compound ID | 2c0HTPb6aAS |
|---|---|
| InChI | InChI=1S/C20H27N3O5/c1-19(2,3)27-17(25)14(22-18(26)28-20(4,5)6)11-13-12-21-15-9-7-8-10-23(15)16(13)24/h7-10,12,14H,11H2,1-6H3,(H,22,26)/t14-/m1/s1 |
| InChIKey | JIGUYKNUPNKZDN-CQSZACIVSA-N |
| Mol Weight | 389.45 g/mol |
| Molecular Formula | C20H27N3O5 |
| Exact Mass | 389.195071 g/mol |
| Enantiomer InChIKey | JIGUYKNUPNKZDN-AWEZNQCLSA-N |
| Racemate InChIKey | JIGUYKNUPNKZDN-UHFFFAOYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
4H-pyrido[1,2-a]pyrimidine-3-propanoic acid, 2,7-dimethyl-4-oxo-,ethyl ester
4H-pyrido[1,2-a]pyrimidine-3-propanoic acid, 7-bromo-2-methyl-4-oxo-, ethyl ester
4H-Pyrido[1,2-a]pyrimidine-3-acetic acid, 6,8-dimethyl-4-oxo-, ethyl ester
4H-pyrido[1,2-a]pyrimidine-3-propanoic acid, 7-bromo-2-methyl-4-oxo-
7-methyl-2,3-dihydrocyclopenta[d]pyrido[1,2-a]pyrimidin-10(1H)-one
3-Ethyl-2-(hydroxymethyl)-6-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
3-Ethyl-6-(hydroxymethyl)-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
3-Acetyl-2,6-dimethyl-4H-pyrido[1,2-a]pyrimidin-4-one
3-(1'-Hydroxyethyl)-2,6-dimethyl-4H-pyrido[1,2-a]pyrimidin-4-one
2-hydroxy-3-cyclohexylidene-4-oxo-8-methyl-4,5-dihydropyrimido[1.2-a]pyridine
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of agonists and antagonists for central glutamate receptors by a novel ‘ring switching’ strategy 1 | Journal of the Chemical Society, Perkin Transactions 1 | 1997 |